Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Opportunity for USA, Canada, and International Research Institutions to Develop a COVID-19 Vaccine for Low and Middle-Income Countries

ELIGIBILITY:

Geographic Focus

USA: AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew York CityNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashington, DCWashingtonWest VirginiaWisconsinWyoming

USA Territories: American Samoa (USA)Guam (USA)Puerto Rico (USA)Virgin Islands (USA)Northern Mariana Islands (USA)

USA Compact Free Associations: The Federated States of Micronesia (USA)  Marshall Islands (USA)  Republic of Palau (USA)

Canada: AlbertaBritish ColumbiaManitobaNew BrunswickNewfoundland and LabradorNorthwest TerritoriesNova ScotiaNunavutOntarioPrince Edward IslandQuebecSaskatchewanYukon

GrantRegions Object ( [regions] => Array ( ) [is_initialized] => [error_messages] => Array ( ) [qm] => QueryManager Object ( [is_debug] => [conn] => mysqli Object ( [affected_rows] => 9 [client_info] => mysqlnd 5.0.12-dev - 20150407 - $Id: 3591daad22de08524295e1bd073aceeff11e6579 $ [client_version] => 50012 [connect_errno] => 0 [connect_error] => [errno] => 0 [error] => [error_list] => Array ( ) [field_count] => 2 [host_info] => 172.16.38.157 via TCP/IP [info] => [insert_id] => 0 [server_info] => 5.5.5-10.5.18-MariaDB [server_version] => 100518 [stat] => Uptime: 3101204 Threads: 256 Questions: 530079303 Slow queries: 1306 Opens: 117581 Open tables: 2722 Queries per second avg: 170.926 [sqlstate] => 00000 [protocol_version] => 10 [thread_id] => 86023167 [warning_count] => 0 ) ) [has_regions] => 1 [state_names] => Array ( [0] => Alabama; [1] => Alaska; [2] => Arizona; [3] => Arkansas; [4] => California; [5] => Colorado; [6] => Connecticut; [7] => Delaware; [8] => Florida; [9] => Georgia; [10] => Hawaii; [11] => Idaho; [12] => Illinois; [13] => Indiana; [14] => Iowa; [15] => Kansas; [16] => Kentucky; [17] => Louisiana; [18] => Maine; [19] => Maryland; [20] => Massachusetts; [21] => Michigan; [22] => Minnesota; [23] => Mississippi; [24] => Missouri; [25] => Montana; [26] => Nebraska; [27] => Nevada; [28] => New Hampshire; [29] => New Jersey; [30] => New Mexico; [31] => New York; [32] => North Carolina; [33] => North Dakota; [34] => New York City; [35] => Ohio; [36] => Oklahoma; [37] => Oregon; [38] => Pennsylvania; [39] => Rhode Island; [40] => South Carolina; [41] => South Dakota; [42] => Tennessee; [43] => Texas; [44] => Utah; [45] => Vermont; [46] => Virginia; [47] => Washington; [48] => Washington, DC; [49] => West Virginia; [50] => Wisconsin; [51] => Wyoming; ) [province_names] => Array ( [0] => Alberta; [1] => British Columbia; [2] => Manitoba; [3] => New Brunswick; [4] => Newfoundland and Labrador; [5] => Northwest Territories; [6] => Nova Scotia; [7] => Nunavut; [8] => Ontario; [9] => Prince Edward Island; [10] => Quebec; [11] => Saskatchewan; [12] => Yukon; ) [country_names] => Array ( [1] => American Samoa (USA) [2] => The Federated States of Micronesia (USA) [3] => Guam (USA) [4] => Marshall Islands (USA) [5] => Puerto Rico (USA) [6] => Republic of Palau (USA) [7] => Virgin Islands (USA) [8] => Northern Mariana Islands (USA) ) [is_israel] => 1 [territories] => Array ( [0] => American Samoa (USA); [1] => Guam (USA); [2] => Puerto Rico (USA); [3] => Virgin Islands (USA); [4] => Northern Mariana Islands (USA); ) [free_associations] => Array ( [0] => The Federated States of Micronesia (USA) [1] => Marshall Islands (USA) [2] => Republic of Palau (USA) ) )

Israel

International country outside of the USA, Israel and Canada.

Research Grant - COVID-19 Vaccine Development for LMICs

Pfizer Global Medical Grants (GMG) and BioNTech


Agency: Foundation

GrantWatch ID #201706

Grant Description

Opportunity for USA, Canada, and International research institutions in eligible countries to develop a Coronavirus (COVID-19) vaccine for low and middle-income countries. The purpose of the opportunity is to provide researchers with an existing vaccine as a foundation for further research and development. Requests from China, Hong Kong, Macau, and Taiwan are ineligible.

The intent of this RFP is to support COVID-19 vaccine development for LMICs. The support provided by Pfizer will be through the provision of the Pfizer-BioNTech COVID-19 Vaccine for comparator studies. No funding will be provided. Pfizer-BioNTech is particularly interested in supporting research in the following areas:

  • Clinical studies designed to lead to approval and availability of new COVID-19 vaccine(s)
  • Such vaccine(s) must be intended to protect large populations in LMIC, based on study design, GMP manufacturing capacity, product characteristics, the applicant’s ability to manage timely GCP-compliant clinical trials and regulatory filings and other relevant factors

Need help writing this grant?

Eligibility:

  • Others (see text field entitled "Additional Eligibility Criteria" for clarification)

Additional Eligibility Criteria:

Geographic Scope: Global, with preference given to organizations with a presence in a low- and
middle-income country (LMIC)*
*Requests from China, Hong Kong, Macau, and Taiwan are ineligible as these markets are
outside the Pfizer/BioNTech collaboration

Applicant Eligibility Criteria:
- The institution and principal investigator (PI) must be based in one of the eligible countries noted above.
- Only organizations are eligible to receive grants, not individuals or medical practice groups.
- The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
- Applicant must be affiliated with a host institution
- Requests from China, Hong Kong, Macau, and Taiwan are ineligible as these markets are outside the Pfizer/BioNTech collaboration

- Preclinical studies will not be considered unless there is a regulatory GLP requirement to support clinical studies.
- Studies seeking to use doses of BNT162b2 procured through contracted supply or advanced purchase agreements are outside the scope of this RFP.

Pre-Application Information:

Key Dates:
- RFP start date: February 17, 2022
- RFP end date: December 31, 2022
- Grant applications may be submitted throughout the year and application reviews and decisions will be completed on a rolling basis
- Anticipated Grant Award Notification Date: The intent is to review and send out decision notifications within 8-10 weeks of submission
- Grants will be distributed following a fully executed agreement and submission of Final Protocol, documentation of IRB/IEC approval, regulatory approval (if applicable), exemption or waiver

- All applicants will be notified via email by the dates noted above.
- Applicants may be asked for additional clarification during the review period.

Additional Funding Information:

Estimated Size of Grant:

No funding will be provided.

Term of Contract:

Anticipated Project Length: 1-2 years

Contact Information:

Application: http://www.cybergrants.com/pfizer/Research

If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Derek Warnick (derek.warnick@pfizer.com), with the subject line “COVID-19 Vaccine Development in LMIC.”

Live Chat Chat Now